Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Pastacaldi, S; Teixeira, R; Montalto, P; Rolles, K; Burroughs, AK
   Hepatic artery thrombosis after orthotopic liver transplantation: A reviewof nonsurgical causes
   LIVER TRANSPLANTATION
   
   S. Pastacaldi et al., "Hepatic artery thrombosis after orthotopic liver transplantation: A reviewof nonsurgical causes", LIVER TRANS, 7(2), 2001, pp. 75-81
2. Grimm, DR; Colter, MB; Braunschweig, M; Alexander, LJ; Neame, PJ; Kim, HKW
   Porcine factor V: cDNA cloning, gene mapping, three-dimensional protein modeling of membrane binding sites and comparative anatomy of domains
   CELLULAR AND MOLECULAR LIFE SCIENCES
   
   D.R. Grimm et al., "Porcine factor V: cDNA cloning, gene mapping, three-dimensional protein modeling of membrane binding sites and comparative anatomy of domains", CELL MOL L, 58(1), 2001, pp. 148-159
3. Gold, B; Hanson, M; Dean, M
   Two rare confounding polymorphisms proximal to the factor V Leiden mutation
   MOLECULAR DIAGNOSIS
   
   B. Gold et al., "Two rare confounding polymorphisms proximal to the factor V Leiden mutation", MOL DIAGN, 6(2), 2001, pp. 137-140
4. Rhodes, RB; Lewis, K; Shultz, J; Huber, S; Voelkerding, KV; Leonard, DGB; Tsongalis, GJ; Kephart, DD
   Analysis of the factor V Leiden mutation using the READIT Assay
   MOLECULAR DIAGNOSIS
   
   R.B. Rhodes et al., "Analysis of the factor V Leiden mutation using the READIT Assay", MOL DIAGN, 6(1), 2001, pp. 55-61
5. Kamphuisen, PW; Eikenboom, JCJ; Bertina, RM
   Elevated factor VIII levels and the risk of thrombosis
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   P.W. Kamphuisen et al., "Elevated factor VIII levels and the risk of thrombosis", ART THROM V, 21(5), 2001, pp. 731-738
6. Sampram, ESK; Lindblad, B
   The impact of Factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions
   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
   
   E.S.K. Sampram e B. Lindblad, "The impact of Factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions", EUR J VAS E, 22(2), 2001, pp. 134-138
7. Lopaciuk, S; Bykowska, K; Kwiecinski, H; Mickielewicz, A; Czlonkowska, A; Mendel, T; Kuczynska-Zardzewialy, A; Szelagowska, D; Windyga, J; Schroder, W; Herrmann, FH; Jedrzejowska, H
   Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   S. Lopaciuk et al., "Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke", CL APPL T-H, 7(4), 2001, pp. 346-350
8. Mira, Y; Todoli, J; Alonso, R; Mico, ML; Vaya, A; Ferrando, F; Estelles, A; Villa, P; Aznar, J
   Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   Y. Mira et al., "Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases", CL APPL T-H, 7(3), 2001, pp. 234-237
9. Wuthrich, RP
   Factor V Leiden mutation: potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis
   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
   
   R.P. Wuthrich, "Factor V Leiden mutation: potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis", CURR OP NEP, 10(3), 2001, pp. 409-414
10. Linfert, DR; Tsongalis, GJ
    Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphisms
    DIAGNOSTIC MOLECULAR PATHOLOGY
    
    D.R. Linfert e G.J. Tsongalis, "Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphisms", DIAGN MOL P, 10(2), 2001, pp. 111-115
11. Quincampoix, JC; Legarff, M; Rittling, C; Andiva, S; Toulon, P
    Modification of the ProC (R) Global assay using dilution of patient plasmain factor V-depleted plasma as a screening assay for factor V Leiden mutation
    BLOOD COAGULATION & FIBRINOLYSIS
    
    J.C. Quincampoix et al., "Modification of the ProC (R) Global assay using dilution of patient plasmain factor V-depleted plasma as a screening assay for factor V Leiden mutation", BL COAG FIB, 12(7), 2001, pp. 569-576
12. Pecheniuk, NM; Morris, CP; Walsh, TP; Marsh, NA
    The factor V HR2 haplotype: prevalence and association of the A4070G and A6755G polymorphisms
    BLOOD COAGULATION & FIBRINOLYSIS
    
    N.M. Pecheniuk et al., "The factor V HR2 haplotype: prevalence and association of the A4070G and A6755G polymorphisms", BL COAG FIB, 12(3), 2001, pp. 201-206
13. Redondo, M; Carroll, VA; Mauron, T; Biasiutti, FD; Binder, BR; Lammle, B; Wuillemin, WA
    Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha 2-antiplasmin complex is an independent predictor of coronary re-events
    BLOOD COAGULATION & FIBRINOLYSIS
    
    M. Redondo et al., "Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha 2-antiplasmin complex is an independent predictor of coronary re-events", BL COAG FIB, 12(1), 2001, pp. 17-24
14. Isermann, B; Hendrickson, SB; Hutley, K; Wing, M; Weiler, H
    Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block
    DEVELOPMENT
    
    B. Isermann et al., "Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block", DEVELOPMENT, 128(6), 2001, pp. 827-838
15. Irani-Hakime, N; Tamim, H; Elias, G; Choueiry, S; Kreidy, R; Daccache, JL; Almawi, WY
    Factor V R506Q mutation-Leiden: An independent risk factor for venous thrombosis but not coronary artery disease
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    N. Irani-Hakime et al., "Factor V R506Q mutation-Leiden: An independent risk factor for venous thrombosis but not coronary artery disease", J THROMB TH, 11(2), 2001, pp. 111-116
16. Pinney, SP; Rabbani, LE
    Myocardial infarction in patients with normal coronary arteries: Proposed pathogenesis and predisposing risk factors
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    S.P. Pinney e L.E. Rabbani, "Myocardial infarction in patients with normal coronary arteries: Proposed pathogenesis and predisposing risk factors", J THROMB TH, 11(1), 2001, pp. 11-17
17. Verdu, A; Cazorla, MR; Granados, MA; Alonso, JA; Casado, LF
    Basilar artery thrombosis in a child heterozygous for factor V Leiden mutation
    PEDIATRIC NEUROLOGY
    
    A. Verdu et al., "Basilar artery thrombosis in a child heterozygous for factor V Leiden mutation", PED NEUROL, 24(1), 2001, pp. 69-71
18. Gopel, W; Gortner, L; Kohlmann, T; Schultz, C; Moller, J
    Low prevalence of large intraventricular haemorrhage in very low birthweight infants carrying the factor V Leiden or prothrombin G20210A mutation
    ACTA PAEDIATRICA
    
    W. Gopel et al., "Low prevalence of large intraventricular haemorrhage in very low birthweight infants carrying the factor V Leiden or prothrombin G20210A mutation", ACT PAEDIAT, 90(9), 2001, pp. 1021-1024
19. Topaloglu, R; Akierli, C; Bakkaloglu, A; Aydintug, O; Ozen, S; Besbas, N; Ozcelik, T
    Survey of factor V Leiden and prothrombin gene mutations in systemic lupuserythematosus
    CLINICAL RHEUMATOLOGY
    
    R. Topaloglu et al., "Survey of factor V Leiden and prothrombin gene mutations in systemic lupuserythematosus", CLIN RHEUMA, 20(4), 2001, pp. 259-261
20. Miles, JS; Miletich, JP; Goldhaber, SZ; Hennekens, CH; Ridker, PM
    G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    J.S. Miles et al., "G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism", J AM COL C, 37(1), 2001, pp. 215-218
21. Gurgey, A; Haznedaroglu, IC; Egesel, T; Buyukasik, Y; Ozcebe, OI; Sayinalp, N; Dundar, SV; Bayraktar, Y
    Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis
    AMERICAN JOURNAL OF HEMATOLOGY
    
    A. Gurgey et al., "Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis", AM J HEMAT, 67(2), 2001, pp. 107-111
22. Weiss, HJ; Lages, B; Zheng, SL; Hayward, CPM
    Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation
    AMERICAN JOURNAL OF HEMATOLOGY
    
    H.J. Weiss et al., "Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation", AM J HEMAT, 66(2), 2001, pp. 130-139
23. Coen, D; Zadro, R; Honovic, L; Banfic, L; Rukavina, AS
    Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism
    CROATIAN MEDICAL JOURNAL
    
    D. Coen et al., "Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism", CROAT MED J, 42(4), 2001, pp. 488-492
24. Franco, RF; Reitsma, PH
    Genetic risk factors of venous thrombosis
    HUMAN GENETICS
    
    R.F. Franco e P.H. Reitsma, "Genetic risk factors of venous thrombosis", HUM GENET, 109(4), 2001, pp. 369-384
25. Merlini, PA; Ardissino, D
    Genetic polymorphisms to evaluate the risk of myocardial infarction: a long way away
    THROMBOSIS AND HAEMOSTASIS
    
    P.A. Merlini e D. Ardissino, "Genetic polymorphisms to evaluate the risk of myocardial infarction: a long way away", THROMB HAEM, 86(5), 2001, pp. 1136-1138
26. Saigo, M; Abe, S; Ogawa, M; Yamashita, T; Biro, S; Minagoe, S; Maruyama, I; Tei, C
    Imbalance of plasminogen activator inhibitor-I/tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction
    THROMBOSIS AND HAEMOSTASIS
    
    M. Saigo et al., "Imbalance of plasminogen activator inhibitor-I/tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction", THROMB HAEM, 86(5), 2001, pp. 1197-1203
27. Butenas, S; Branda, RF; van't Veer, C; Cawthern, KM; Mann, KG
    Platelets and phospholipids in tissue factor-initiated thrombin generation
    THROMBOSIS AND HAEMOSTASIS
    
    S. Butenas et al., "Platelets and phospholipids in tissue factor-initiated thrombin generation", THROMB HAEM, 86(2), 2001, pp. 660-667
28. Martinelli, I
    Risk factors in venous thromboembolism
    THROMBOSIS AND HAEMOSTASIS
    
    I. Martinelli, "Risk factors in venous thromboembolism", THROMB HAEM, 86(1), 2001, pp. 395-403
29. Heit, JA; Silverstein, MD; Mohr, DN; Petterson, TM; Lohse, CM; O'Fallon, WM; Melton, LJ
    The epidemiology of venous thromboembolism in the community
    THROMBOSIS AND HAEMOSTASIS
    
    J.A. Heit et al., "The epidemiology of venous thromboembolism in the community", THROMB HAEM, 86(1), 2001, pp. 452-463
30. Hoffman, M; Monroe, DM
    A cell-based model of hemostasis
    THROMBOSIS AND HAEMOSTASIS
    
    M. Hoffman e D.M. Monroe, "A cell-based model of hemostasis", THROMB HAEM, 85(6), 2001, pp. 958-965
31. Izumi, T; Kim, SW; Greist, A; Macedo-Ribeiro, S; Fuentes-Prior, P; Bode, W; Kane, WH; Ortel, TL
    Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants - Identification of two antigenic epitopes involved in phospholipid binding
    THROMBOSIS AND HAEMOSTASIS
    
    T. Izumi et al., "Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants - Identification of two antigenic epitopes involved in phospholipid binding", THROMB HAEM, 85(6), 2001, pp. 1048-1054
32. Bauer, KA
    Conventional fibrinolytic assays for the evaluation of patients with venous thrombosis: Don't bother
    THROMBOSIS AND HAEMOSTASIS
    
    K.A. Bauer, "Conventional fibrinolytic assays for the evaluation of patients with venous thrombosis: Don't bother", THROMB HAEM, 85(3), 2001, pp. 377-378
33. Clark, P; Sattar, N; Walker, ID; Greer, IA
    The Glasgow outcome, APCR and lipid (GOAL) pregnancy study: Significance of pregnancy associated activated protein C resistance
    THROMBOSIS AND HAEMOSTASIS
    
    P. Clark et al., "The Glasgow outcome, APCR and lipid (GOAL) pregnancy study: Significance of pregnancy associated activated protein C resistance", THROMB HAEM, 85(1), 2001, pp. 30-35
34. Hoekema, L; Castoldi, E; Tans, G; Girelli, D; Gemmati, D; Bernardi, F; Rosing, J
    Functional properties of factor V and factor Va encoded by the R2-gene
    THROMBOSIS AND HAEMOSTASIS
    
    L. Hoekema et al., "Functional properties of factor V and factor Va encoded by the R2-gene", THROMB HAEM, 85(1), 2001, pp. 75-81
35. Schwarz, T; Siegert, G; Mikulin, U; Gehrisch, S; Runge, E; Berg, LP; Koch, R; Schellong, SM
    Patients with persistent APC-resistance without factor V Leiden mutation
    VASA-JOURNAL OF VASCULAR DISEASES
    
    T. Schwarz et al., "Patients with persistent APC-resistance without factor V Leiden mutation", VASA, 30(1), 2001, pp. 24-27
36. Linden, MD; Schneider, M; Erber, WN
    Factor V-LEIDEN and cardiopulmonary bypass: investigation of haemostatic parameters and the effect of aprotinin using an ex vivo model
    PERFUSION-UK
    
    M.D. Linden et al., "Factor V-LEIDEN and cardiopulmonary bypass: investigation of haemostatic parameters and the effect of aprotinin using an ex vivo model", PERFUSION-U, 16(6), 2001, pp. 476-484
37. Rubinstein, R; Novitzky, N
    Thrombo-embolic disease - Prevalence of factor V Leiden in the Western Cape
    SOUTH AFRICAN MEDICAL JOURNAL
    
    R. Rubinstein e N. Novitzky, "Thrombo-embolic disease - Prevalence of factor V Leiden in the Western Cape", S AFR MED J, 91(5), 2001, pp. 406-406
38. Schleinitz, N; Veit, V; Chouquet, D; Seux, V; Arnoux, D; Mokart, D; Lelong, B; Alessi, MC; Kaplanski, G; Harle, JR
    Acquired factor V inhibitor: aetiology, bleeding risk and treatment with regard to three cases.
    REVUE DE MEDECINE INTERNE
    
    N. Schleinitz et al., "Acquired factor V inhibitor: aetiology, bleeding risk and treatment with regard to three cases.", REV MED IN, 22(11), 2001, pp. 1119-1123
39. Gill, RQ; Sterling, RK
    Acute liver failure
    JOURNAL OF CLINICAL GASTROENTEROLOGY
    
    R.Q. Gill e R.K. Sterling, "Acute liver failure", J CLIN GAST, 33(3), 2001, pp. 191-198
40. Pallotta, R; Dalpra, L; Miozzo, M; Ehresmann, T; Fusilli, P
    A patient defines the interstitial 1q deletion syndrome characterized by antithrombin III deficiency
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    R. Pallotta et al., "A patient defines the interstitial 1q deletion syndrome characterized by antithrombin III deficiency", AM J MED G, 104(4), 2001, pp. 282-286
41. Psaty, BM; Smith, NL; Lemaitre, RN; Vos, HL; Heckbert, SR; LaCroix, AZ; Rosendaal, FR
    Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    B.M. Psaty et al., "Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women", J AM MED A, 285(7), 2001, pp. 906-913
42. Toulon, P; Adda, R; Perez, P
    Sensitivity of the ProC((R)) global assay for protein C pathway abnormalities. Clinical experience in 899 unselected patients with venous thromboembolism
    THROMBOSIS RESEARCH
    
    P. Toulon et al., "Sensitivity of the ProC((R)) global assay for protein C pathway abnormalities. Clinical experience in 899 unselected patients with venous thromboembolism", THROMB RES, 104(2), 2001, pp. 93-103
43. Hsu, TS; Hsu, LA; Chang, CJ; Sun, CF; Ko, YL; Kuo, CT; Chiang, CW; Lee, YS
    Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study
    THROMBOSIS RESEARCH
    
    T.S. Hsu et al., "Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study", THROMB RES, 102(5), 2001, pp. 387-395
44. Madonna, P; Piemontino, U; De Stefano, V; Albisinni, R; Cerbone, AM; Di Minno, G
    Coexistence of thrombophilic gene polymorphisms among 559 unrelated consecutive patients with a history of thrombosis
    THROMBOSIS RESEARCH
    
    P. Madonna et al., "Coexistence of thrombophilic gene polymorphisms among 559 unrelated consecutive patients with a history of thrombosis", THROMB RES, 101(4), 2001, pp. 317-319
45. Hankey, GJ; Eikelboom, JW; van Bockxmeer, FM; Lofthouse, E; Staples, N; Baker, RI
    Inherited thrombophilia in ischemic stroke and its pathogenic subtypes
    STROKE
    
    G.J. Hankey et al., "Inherited thrombophilia in ischemic stroke and its pathogenic subtypes", STROKE, 32(8), 2001, pp. 1793-1799
46. Abramson, N; Abramson, S
    Hypercoagulability: Clinical assessment and treatment
    SOUTHERN MEDICAL JOURNAL
    
    N. Abramson e S. Abramson, "Hypercoagulability: Clinical assessment and treatment", SOUTH MED J, 94(10), 2001, pp. 1013-1020
47. Eldridge, J; Dilley, A; Austin, H; EL-Jamil, M; Wolstein, L; Doris, J; Hooper, WC; Meehan, PL; Evatt, B
    The role of protein C, protein S, and resistance to activated protein C inLegg-Perthes disease
    PEDIATRICS
    
    J. Eldridge et al., "The role of protein C, protein S, and resistance to activated protein C inLegg-Perthes disease", PEDIATRICS, 107(6), 2001, pp. 1329-1334
48. Catto, AJ
    Genetic aspects of the hemostatic system in cerebrovascular disease
    NEUROLOGY
    
    A.J. Catto, "Genetic aspects of the hemostatic system in cerebrovascular disease", NEUROLOGY, 57(5), 2001, pp. S24-S30
49. Undas, A; Williams, EB; Butenas, S; Orfeo, T; Mann, KG
    Homocysteine inhibits inactivation of Factor Va by activated protein C
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    A. Undas et al., "Homocysteine inhibits inactivation of Factor Va by activated protein C", J BIOL CHEM, 276(6), 2001, pp. 4389-4397
50. Curat, CA; Eck, M; Dervillez, X; Vogel, WF
    Mapping of epitopes in discoidin domain receptor 1 critical for collagen binding
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    C.A. Curat et al., "Mapping of epitopes in discoidin domain receptor 1 critical for collagen binding", J BIOL CHEM, 276(49), 2001, pp. 45952-45958
51. Myles, T; Yun, TH; Hall, SW; Leung, LLK
    An extensive interaction interface between thrombin and factor V is required for factor V activation
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    T. Myles et al., "An extensive interaction interface between thrombin and factor V is required for factor V activation", J BIOL CHEM, 276(27), 2001, pp. 25143-25149
52. Zeibdawi, AR; Pryzdial, ELG
    Mechanism of factor Va inactivation by plasmin - Loss of A2 and A3 domainsfrom a Ca2+-dependent complex of fragments bound to phospholipid
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    A.R. Zeibdawi e E.L.G. Pryzdial, "Mechanism of factor Va inactivation by plasmin - Loss of A2 and A3 domainsfrom a Ca2+-dependent complex of fragments bound to phospholipid", J BIOL CHEM, 276(23), 2001, pp. 19929-19936
53. Kalafatis, M; Mann, KG
    The role of the membrane in the inactivation of factor Va by plasmin - Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M. Kalafatis e K.G. Mann, "The role of the membrane in the inactivation of factor Va by plasmin - Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function", J BIOL CHEM, 276(21), 2001, pp. 18614-18623
54. Tripodi, A; Mannucci, PM
    Laboratory investigation of thrombophilia
    CLINICAL CHEMISTRY
    
    A. Tripodi e P.M. Mannucci, "Laboratory investigation of thrombophilia", CLIN CHEM, 47(9), 2001, pp. 1597-1606
55. Reyes, AA; Ugozzoli, LA; Lowery, JD; Breneman, JW; Hixson, CS; Press, RD; Wallace, RB
    Linked linear amplification: A new method for the amplification of DNA
    CLINICAL CHEMISTRY
    
    A.A. Reyes et al., "Linked linear amplification: A new method for the amplification of DNA", CLIN CHEM, 47(1), 2001, pp. 31-40
56. Walker, ID; Greaves, M; Preston, FE
    Investigation and management of heritable thrombophilia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    I.D. Walker et al., "Investigation and management of heritable thrombophilia", BR J HAEM, 114(3), 2001, pp. 512-528
57. Lensen, R; Bertina, RM; Vandenbroucke, JP; Rosendaal, FR
    High factor VIII levels contribute to the thrombotic risk in families withfactor V Leiden
    BRITISH JOURNAL OF HAEMATOLOGY
    
    R. Lensen et al., "High factor VIII levels contribute to the thrombotic risk in families withfactor V Leiden", BR J HAEM, 114(2), 2001, pp. 380-386
58. Spiegel, PC; Jacquemin, M; Saint-Remy, JMR; Stoddard, BL; Pratt, KP
    Structure of a factor VIIIC2 domain-immunoglobulin G4 kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII
    BLOOD
    
    P.C. Spiegel et al., "Structure of a factor VIIIC2 domain-immunoglobulin G4 kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII", BLOOD, 98(1), 2001, pp. 13-19
59. Parker, J; Pagliuca, A; Kitiyakara, T; Whitehead, M; Heaton, N; O'Grady, J; Arya, R
    Discrepancy between phenotype and genotype on screening for factor V Leiden after transplantation
    BLOOD
    
    J. Parker et al., "Discrepancy between phenotype and genotype on screening for factor V Leiden after transplantation", BLOOD, 97(8), 2001, pp. 2525-2526
60. Barrow, RT; Healey, JF; Jacquemin, MG; Saint-Remy, JMR; Lollar, P
    Antigenicity of putative phospholipid membrane-binding residues in factor VIII
    BLOOD
    
    R.T. Barrow et al., "Antigenicity of putative phospholipid membrane-binding residues in factor VIII", BLOOD, 97(1), 2001, pp. 169-174
61. Srivastava, A; Quinn-Allen, MA; Kim, SW; Kane, WH; Lentz, BR
    Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor V-a
    BIOCHEMISTRY
    
    A. Srivastava et al., "Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor V-a", BIOCHEM, 40(28), 2001, pp. 8246-8255
62. Federman, DG; Kirsner, RS
    An update on hypercoagulable disorders
    ARCHIVES OF INTERNAL MEDICINE
    
    D.G. Federman e R.S. Kirsner, "An update on hypercoagulable disorders", ARCH IN MED, 161(8), 2001, pp. 1051-1056
63. Ortel, TL; Mercer, MC; Thames, EH; Moore, KD; Lawson, JH
    Immunologic impact and clinical outcomes after surgical exposure to bovinethrombin
    ANNALS OF SURGERY
    
    T.L. Ortel et al., "Immunologic impact and clinical outcomes after surgical exposure to bovinethrombin", ANN SURG, 233(1), 2001, pp. 88-96
64. Middeldorp, S; Meinardi, JR; Koopman, MMW; van Pampus, ECM; Hamulyak, K; van der Meer, J; Prins, MH; Buller, HR
    A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism
    ANNALS OF INTERNAL MEDICINE
    
    S. Middeldorp et al., "A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism", ANN INT MED, 135(5), 2001, pp. 322-327
65. Bauer, KA
    The thrombophilias: Well-defined risk factors with uncertain therapeutic implications
    ANNALS OF INTERNAL MEDICINE
    
    K.A. Bauer, "The thrombophilias: Well-defined risk factors with uncertain therapeutic implications", ANN INT MED, 135(5), 2001, pp. 367-373
66. Petrovic, D; Zorc, M; Keber, I; Peterlin, B
    Joint effect of G1691A factor V point mutation and factor VII Arg/Gln(353)gene polymorphism on the risk of premature coronary artery disease
    ANNALES DE GENETIQUE
    
    D. Petrovic et al., "Joint effect of G1691A factor V point mutation and factor VII Arg/Gln(353)gene polymorphism on the risk of premature coronary artery disease", ANN GENET, 44(1), 2001, pp. 33-36
67. Lee, R
    Factor V Leiden: A clinical review
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    
    R. Lee, "Factor V Leiden: A clinical review", AM J MED SC, 322(2), 2001, pp. 88-102
68. Meyer, G; Emmerich, J; Helley, D; Arnaud, E; Nicaud, V; Alhenc-Gelas, M; Aiach, M; Fischer, AM; Sors, H; Fiessinger, JN
    Factors v Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis
    AMERICAN JOURNAL OF MEDICINE
    
    G. Meyer et al., "Factors v Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis", AM J MED, 110(1), 2001, pp. 12-15
69. Celik, S; Ovali, E; Baykan, M; Ucar, F; Erdol, C; Durmus, I; Kaplan, S
    Factor V Leiden and its relation to left ventricular thrombus in acute myocardial infarction
    ACTA CARDIOLOGICA
    
    S. Celik et al., "Factor V Leiden and its relation to left ventricular thrombus in acute myocardial infarction", ACT CARDIOL, 56(1), 2001, pp. 1-6
70. Parks, SB; Popovich, BW; Press, RD
    Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and iron overload phenotypes
    AJCP. American journal of clinical pathology
    
    S.B. Parks et al., "Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and iron overload phenotypes", AM J CLIN P, 115(3), 2001, pp. 439-447
71. Riordan, SM; Williams, R
    Use and validation of selection criteria for liver transplantation in acute liver failure
    LIVER TRANSPLANTATION
    
    S.M. Riordan e R. Williams, "Use and validation of selection criteria for liver transplantation in acute liver failure", LIVER TRANS, 6(2), 2000, pp. 170-173
72. Huber, S; McMaster, KJ; Voelkerding, KV
    Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A
    JOURNAL OF MOLECULAR DIAGNOSTICS
    
    S. Huber et al., "Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A", J MOL DIAGN, 2(3), 2000, pp. 153-157
73. Kamphuisen, PW; Rosendaal, FR; Eikenboom, JCJ; Bos, R; Bertina, RM
    Factor V antigen levels and venous thrombosis - Risk profile, interaction with factor V Leiden, and relation with factor VIII antigen levels
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    P.W. Kamphuisen et al., "Factor V antigen levels and venous thrombosis - Risk profile, interaction with factor V Leiden, and relation with factor VIII antigen levels", ART THROM V, 20(5), 2000, pp. 1382-1386
74. Bank, I; Middeldorp, S; Buller, HR
    Hereditary and acquired thrombophilia
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    
    I. Bank et al., "Hereditary and acquired thrombophilia", SEM RESP CR, 21(6), 2000, pp. 483-491
75. Pecheniuk, NM; Walsh, TP; Marsh, NA
    DNA technology for the detection of common genetic variants that predispose to thrombophilia
    BLOOD COAGULATION & FIBRINOLYSIS
    
    N.M. Pecheniuk et al., "DNA technology for the detection of common genetic variants that predispose to thrombophilia", BL COAG FIB, 11(8), 2000, pp. 683-700
76. Aillaud, MF; Morange, P; Juhan, I; Bauters, A; Jude, B; Biron-Andreani, C; Daures, JP; Schved, JF; Pernod, G; Polac, B; Bridey, F; De Prost, D; Borg, JY; Saladin-Theron, C; Le Cam, V; Denninger, MH; Truchaud, F; Trossaert, M; Boinot, C; Sultan, Y; Delahousse, B; Fimbel, B; Gruel, Y; Houbouyan, L; Bihour, C; Vergnes, C; Dutrillaux, F; Lorenzini, JL; Julia, A; Deschamps, A; Favier, R; Freyburger, G; Trzeciak, MC; Berruyer, M; Doumergue, G; Gris, JC; Toulon, P; Montpied, G; Marques-Verdier, A; Lequerrec, A; Guerin, V; Massignon, D
    Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study
    BLOOD COAGULATION & FIBRINOLYSIS
    
    M.F. Aillaud et al., "Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study", BL COAG FIB, 11(6), 2000, pp. 511-518
77. Siegert, G; Kostka, H; Gehrisch, S; Schwarz, T; Schellong, S; Jaross, W
    Method-dependent influence of certain polymorphisms in the factor VB-domain on the response to activated protein C
    BLOOD COAGULATION & FIBRINOLYSIS
    
    G. Siegert et al., "Method-dependent influence of certain polymorphisms in the factor VB-domain on the response to activated protein C", BL COAG FIB, 11(6), 2000, pp. 519-527
78. Toulon, P; Halbmeyer, WM; Hafner, G; Schmitt, Y; Randgard, B; Odpadlik, M; Van den Eynden, C; Wagner, C
    Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation
    BLOOD COAGULATION & FIBRINOLYSIS
    
    P. Toulon et al., "Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation", BL COAG FIB, 11(5), 2000, pp. 447-454
79. Pecheniuk, NM; Marsh, NA; Walsh, TP
    Multiple analysis of three common genetic alterations associated with thrombophilia
    BLOOD COAGULATION & FIBRINOLYSIS
    
    N.M. Pecheniuk et al., "Multiple analysis of three common genetic alterations associated with thrombophilia", BL COAG FIB, 11(2), 2000, pp. 183-189
80. Nicolaes, GAF; Villoutreix, BO; Dahlback, B
    Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex
    BLOOD COAGULATION & FIBRINOLYSIS
    
    G.A.F. Nicolaes et al., "Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex", BL COAG FIB, 11(1), 2000, pp. 89-100
81. Yetkin, E; Erbay, AR; Ayaz, S; Ileri, M; Yanik, A; Yetkin, G; Cehreli, S; Goksel, S
    Predictors of left ventricular thrombus formation in patients with anterior myocardial infarction: role of activated protein C resistance
    CORONARY ARTERY DISEASE
    
    E. Yetkin et al., "Predictors of left ventricular thrombus formation in patients with anterior myocardial infarction: role of activated protein C resistance", CORON ART D, 11(3), 2000, pp. 269-272
82. Quehenberger, P; Handler, S; Mannhalter, C; Pabinger-Fasching, I; Speiser, W
    Evaluation of a highly specific functional test for the detection of factor V Leiden
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
    
    P. Quehenberger et al., "Evaluation of a highly specific functional test for the detection of factor V Leiden", INT J CL L, 30(3), 2000, pp. 113-117
83. Gowda, MS; Zucker, ML; Vacek, JL; Carriger, WL; Van Laeys, DL; Rachel, JM; Strope, BD
    Incidence of factor V Leiden in patients with acute myocardial infarction
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    M.S. Gowda et al., "Incidence of factor V Leiden in patients with acute myocardial infarction", J THROMB TH, 9(1), 2000, pp. 43-45
84. Makris, TK; Krespi, PG; Hatzizacharias, AN; Gialeraki, AE; Anastasiadis, G; Triposkiadis, FK; Mandalaki, T; Kyriakidis, MK
    Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension
    AMERICAN JOURNAL OF HYPERTENSION
    
    T.K. Makris et al., "Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension", AM J HYPERT, 13(1), 2000, pp. 61-65
85. Jeon, HK; Youn, HJ; Yoo, KD; Park, JW; Kim, HY; Rhim, HY; Chae, JS; Kim, JH; Choi, KB; Hong, SJ
    Transthoracic echocardiographic demonstration of massive pulmonary thrombus caused by protein C deficiency
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
    
    H.K. Jeon et al., "Transthoracic echocardiographic demonstration of massive pulmonary thrombus caused by protein C deficiency", J AM S ECHO, 13(7), 2000, pp. 682-684
86. Toulon, P; Perez, P
    Screening for risk factors for thrombosis using a new generation of assaysdeveloped to evaluate the functionality of the protein C anticoagulant pathway
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    
    P. Toulon e P. Perez, "Screening for risk factors for thrombosis using a new generation of assaysdeveloped to evaluate the functionality of the protein C anticoagulant pathway", HEMAT ONCOL, 14(2), 2000, pp. 379
87. Kajitani, M; Ozdemir, A; Aguinaga, M; Jazieh, AR; Flick, JT; Antakli, T
    Severe hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product
    JOURNAL OF CARDIAC SURGERY
    
    M. Kajitani et al., "Severe hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product", J CARDIAC S, 15(6), 2000, pp. 378-382
88. Van de Water, NS; French, JK; Lund, M; Hyde, TA; White, HD; Browett, PJ
    Prevalence of factor V Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    N.S. Van de Water et al., "Prevalence of factor V Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction", J AM COL C, 36(3), 2000, pp. 717-722
89. Ioannou, HV; Mitsis, M; Eleftheriou, A; Matsagas, M; Nousias, V; Rigopoulos, C; Vartholomatos, G; Kappas, AM
    The prevalence of Factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece
    INTERNATIONAL ANGIOLOGY
    
    H.V. Ioannou et al., "The prevalence of Factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece", INT ANGIOL, 19(4), 2000, pp. 314-318
90. Le, W; Yu, JD; Lu, L; Tao, R; You, B; Cai, X; Gao, WJ; Huang, W; He, RM; Chen, Z; Gong, LS
    Arg485Lys polymorphism of factor V increases the risk of coronary artery disease in a Chinese population
    CHINESE MEDICAL JOURNAL
    
    W. Le et al., "Arg485Lys polymorphism of factor V increases the risk of coronary artery disease in a Chinese population", CHIN MED J, 113(11), 2000, pp. 963-966
91. Angchaisuksiri, P; Pingsuthiwong, S; Aryuchai, K; Busabaratana, M; Sura, T; Atichartakarn, V; Sritara, P
    Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population
    AMERICAN JOURNAL OF HEMATOLOGY
    
    P. Angchaisuksiri et al., "Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population", AM J HEMAT, 65(2), 2000, pp. 119-122
92. Irani-Hakime, N; Tamim, H; Kreidy, R; Almawi, WY
    The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese
    AMERICAN JOURNAL OF HEMATOLOGY
    
    N. Irani-Hakime et al., "The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese", AM J HEMAT, 65(1), 2000, pp. 45-49
93. Hoekema, L; Rosing, J; Tans, G
    An assay to quantify the two plasma isoforms of Factor V
    THROMBOSIS AND HAEMOSTASIS
    
    L. Hoekema et al., "An assay to quantify the two plasma isoforms of Factor V", THROMB HAEM, 84(6), 2000, pp. 1066-1071
94. Doggen, CJM; de Visser, MCH; Vos, HL; Bertina, RM; Cats, VM; Rosendaal, FR
    The HR2 haplotype of factor V is not associated with the risk of myocardial infarction
    THROMBOSIS AND HAEMOSTASIS
    
    C.J.M. Doggen et al., "The HR2 haplotype of factor V is not associated with the risk of myocardial infarction", THROMB HAEM, 84(5), 2000, pp. 815-818
95. Bauer, KA; Humphries, S; Smillie, B; Li, L; Cooper, JA; Barzegar, S; Rosenberg, RD; Miller, GJ
    Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations
    THROMBOSIS AND HAEMOSTASIS
    
    K.A. Bauer et al., "Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations", THROMB HAEM, 84(3), 2000, pp. 396-400
96. Mansourati, J; Da Costa, A; Munier, S; Mercier, B; Tardy, B; Ferec, C; Isaaz, K; Blanc, JJ
    Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography
    THROMBOSIS AND HAEMOSTASIS
    
    J. Mansourati et al., "Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography", THROMB HAEM, 83(6), 2000, pp. 822-825
97. de Visser, MCH; Guasch, JF; Kamphuisen, PW; Vos, HL; Rosendaal, FR; Bertina, RM
    The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis
    THROMBOSIS AND HAEMOSTASIS
    
    M.C.H. de Visser et al., "The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis", THROMB HAEM, 83(4), 2000, pp. 577-582
98. Castoldi, E; Rosing, J; Girelli, D; Hoekema, L; Lunghi, B; Mingozzi, F; Ferraresi, P; Friso, S; Corrocher, R; Tans, G; Bernardi, F
    Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma
    THROMBOSIS AND HAEMOSTASIS
    
    E. Castoldi et al., "Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma", THROMB HAEM, 83(3), 2000, pp. 362-365
99. Voetsch, B; Damasceno, BP; Camargo, ECS; Massaro, A; Bacheschi, LA; Scaff, M; Annichino-Bizzacchi, JM; Arruda, VR
    Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults
    THROMBOSIS AND HAEMOSTASIS
    
    B. Voetsch et al., "Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults", THROMB HAEM, 83(2), 2000, pp. 229-233
100. Renner, W; Koppel, H; Brodmann, M; Pabst, E; Schallmoser, K; Toplak, H; Wascher, TC; Pilger, E
     Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease
     THROMBOSIS AND HAEMOSTASIS
     
     W. Renner et al., "Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease", THROMB HAEM, 83(1), 2000, pp. 20-22